Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EN3835 extension study for cellulite
NCT02942160Phase 2Completed
- Sponsor
- Endo International plc
- Start
- Oct 2016
- Primary completion
- Jun 2018
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of collagenase clostridium histolyticum in cellulite, sponsored by Endo International plc. Primary endpoint: Number of Participants That Were 2-level Composite (CR-PCSS and PR-PCSS) Responders During the Observation Phase. Started Oct 2016; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
cellulite
Beyond the preview
Go deeper on NCT02942160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02942160.